-
Taxonomy & unit
-
us-gaap: CAD and USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Arbutus Biopharma Corp quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2011 to 2023.
- Arbutus Biopharma Corp Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$19.8M, a 15.8% decline year-over-year.
- Arbutus Biopharma Corp Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$77.1M, a 5.7% decline year-over-year.
- Arbutus Biopharma Corp annual Net Income (Loss) Attributable to Parent for 2023 was -$72.8M, a 4.89% decline from 2022.
- Arbutus Biopharma Corp annual Net Income (Loss) Attributable to Parent for 2022 was -$69.5M, a 8.91% increase from 2021.
- Arbutus Biopharma Corp annual Net Income (Loss) Attributable to Parent for 2021 was -$76.2M, a 19.6% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)